Literature DB >> 2454740

WHO cancer pain relief programme.

J Stjernswärd1.   

Abstract

Cancer pain relief is a ubiquitous but neglected public health problem. Every day more than three and a half million people suffer from cancer pain, but only a fraction receive treatment for it. Relatively simple and inexpensive methods of pain relief are available. Adequate pain relief is not reaching a great number of cancer patients in developed countries. In the developing countries, where more than half the world's cancer patients are and where most are incurable at the time of diagnosis, pain relief (often the only relevant human alternative) by and large is not offered. Obstacles to effective cancer pain relief worldwide include poor drug availability, misguided national drug legislation, lack of education of doctors and nurses, underprescribing and underdosing by the professionals, wrong timing of drugs given, fear of addiction and lack of public awareness that pain can be controlled. A World Health Organization (WHO) method has been developed which provides for drugs to be administered immediately if there is pain, to be given 'by the clock' rather than 'on demand' and to be increased from non-opioids (aspirin or paracetamol) to weak opioids (codeine) and then to strong opioids (morphine) until the patient is free from pain--hence the concept of a three-step ladder for cancer pain relief. Field tests have shown that the right drug in the right dose at the right time relieves 80 to 90% of pain. Thus a scientifically valid, relatively inexpensive method suitable for reaching patients at community level does exist.

Entities:  

Mesh:

Year:  1988        PMID: 2454740

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  23 in total

1.  Assessing and treating pain in hospices: current state of evidence-based practices.

Authors:  Keela Herr; Marita Titler; Perry Fine; Sara Sanders; Joe Cavanaugh; John Swegle; Chris Forcucci; Xiongwen Tang
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

2.  Pain management in nursing home residents with cancer.

Authors:  Camilla B Pimentel; Becky A Briesacher; Jerry H Gurwitz; Allison B Rosen; Marc T Pimentel; Kate L Lapane
Journal:  J Am Geriatr Soc       Date:  2015-04       Impact factor: 5.562

3.  Is it possible to detect an improvement in cancer pain management? A comparison of two Norwegian cross-sectional studies conducted 5 years apart.

Authors:  Morten Thronæs; Sunil X Raj; Cinzia Brunelli; Sigrun Saur Almberg; Ola Magne Vagnildhaug; Susanna Bruheim; Birgit Helgheim; Stein Kaasa; Anne Kari Knudsen
Journal:  Support Care Cancer       Date:  2015-12-28       Impact factor: 3.603

Review 4.  Pain in the Elderly.

Authors:  Mark R Jones; Ken P Ehrhardt; Juan G Ripoll; Bharat Sharma; Ira W Padnos; Rachel J Kaye; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-04

5.  Impact of environmental and genetic factors on codeine analgesia.

Authors:  J Desmeules; M P Gascon; P Dayer; M Magistris
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

Review 7.  Palliative care and melanoma: the care of the patient with progressive disease.

Authors:  J N Lickiss
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

8.  [Pain treatment in cancer patients.].

Authors:  R Twycross
Journal:  Schmerz       Date:  1990-06       Impact factor: 1.107

Review 9.  Undertreatment of cancer pain: barriers and remedies.

Authors:  S A Grossman
Journal:  Support Care Cancer       Date:  1993-03       Impact factor: 3.603

Review 10.  Anaplastic gliomas: end-of-life care recommendations.

Authors:  Linda Dirven; Eefje M Sizoo; Martin J B Taphoorn
Journal:  CNS Oncol       Date:  2015-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.